GSK Claims Patent Office Exceeds Authority In Continuation Applications Rule
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline has filed suit against the Patent and Trademark Office to block new rules limiting the number of continuation applications a patent holder can file